A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia
Clinical trial NCT02944383 · COMPLETED
Trial details
- NCT number
- NCT02944383
- Sponsor
- NeuroBo Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-01-11
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.